Hap Trading, LLC Ultragenyx Pharmaceutical Inc. Transaction History
Hap Trading, LLC
- $935 Billion
- Q1 2025
A detailed history of Hap Trading, LLC transactions in Ultragenyx Pharmaceutical Inc. stock. As of the latest transaction made, Hap Trading, LLC holds 80,100 shares of RARE stock, worth $2.73 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
80,100Holding current value
$2.73 Million% of portfolio
0.0%Shares
0 transactions
| Quarter | Operation | Price Per share | shares change | shares Held | SEC Form |
|---|
Others Institutions Holding RARE
# of Institutions
336Shares Held
88.9MCall Options Held
1.08MPut Options Held
1.04M-
Vanguard Group Inc Valley Forge, PA10MShares$340 Million0.01% of portfolio
-
Black Rock Inc. New York, NY5.6MShares$191 Million0.01% of portfolio
-
Sands Capital Management, LLC Arlington, VA4.16MShares$142 Million0.55% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.22MShares$110 Million0.01% of portfolio
-
State Street Corp Boston, MA2.62MShares$89.1 Million0.0% of portfolio
About Ultragenyx Pharmaceutical Inc.
- Ticker RARE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,036,896
- Market Cap $2.38B
- Description
- Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in North America, Europe, and internationally. Its biologic products include Crysvita (burosumab), an antibody targeting fibroblast...